Publications by authors named "Marcelina Zarnowska"
Page 1 of 1
Synopsis of recent research by authors named "Marcelina Zarnowska"
- Recent research by Marcelina Zarnowska primarily focuses on the neuropharmacological effects of 1MeTIQ, particularly its potential as a neuroprotective agent in animal models of schizophrenia, addressing issues like excitotoxicity, oxidative stress, and cognitive impairments associated with the disorder.
- Studies indicate that while 1MeTIQ shows antioxidant properties and may mitigate cell death associated with NMDA receptor inhibition (MK-801), it does not significantly improve behavioral performance in fear conditioning or social interaction tests, suggesting limitations in its therapeutic efficacy in certain contexts.
- Findings also reveal that 1MeTIQ may possess pro-cognitive effects in recognition memory tasks, offering a contrast to traditional treatments like olanzapine, thereby demonstrating the compound's unique mechanisms in influencing monoamine metabolism and anxiety-related behaviors in schizophrenia models.
